LivaNova PLC (NASDAQ:LIVN) Stake Lessened by Tudor Investment Corp ET AL

Tudor Investment Corp ET AL reduced its stake in shares of LivaNova PLC (NASDAQ:LIVN - Free Report) by 14.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 136,345 shares of the company's stock after selling 22,401 shares during the period. Tudor Investment Corp ET AL owned about 0.25% of LivaNova worth $6,314,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of LIVN. Nordea Investment Management AB boosted its position in LivaNova by 22.2% during the 4th quarter. Nordea Investment Management AB now owns 68,711 shares of the company's stock valued at $3,188,000 after purchasing an additional 12,470 shares during the period. Harbor Capital Advisors Inc. bought a new position in shares of LivaNova during the fourth quarter worth about $1,954,000. KBC Group NV increased its holdings in shares of LivaNova by 130.5% in the 4th quarter. KBC Group NV now owns 99,928 shares of the company's stock worth $4,628,000 after acquiring an additional 56,580 shares during the period. PNC Financial Services Group Inc. lifted its position in LivaNova by 29.1% in the 4th quarter. PNC Financial Services Group Inc. now owns 6,311 shares of the company's stock valued at $292,000 after purchasing an additional 1,424 shares during the last quarter. Finally, Rhumbline Advisers boosted its stake in LivaNova by 0.5% during the 4th quarter. Rhumbline Advisers now owns 177,938 shares of the company's stock valued at $8,240,000 after purchasing an additional 899 shares during the period. Institutional investors and hedge funds own 97.64% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the company. Mizuho decreased their price target on LivaNova from $70.00 to $60.00 and set an "outperform" rating for the company in a research note on Wednesday, February 26th. Stifel Nicolaus reduced their price target on shares of LivaNova from $72.00 to $60.00 and set a "buy" rating for the company in a research note on Wednesday, February 26th. The Goldman Sachs Group lowered their price objective on shares of LivaNova from $64.00 to $55.00 and set a "buy" rating on the stock in a research note on Monday, March 3rd. Needham & Company LLC restated a "buy" rating and issued a $64.00 price objective on shares of LivaNova in a report on Monday, March 17th. Finally, Wolfe Research lowered shares of LivaNova from an "outperform" rating to a "peer perform" rating in a research report on Wednesday, February 26th. Two equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, LivaNova has an average rating of "Buy" and an average target price of $61.17.

LivaNova Stock Performance

Shares of LIVN opened at $37.00 on Thursday. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.37 and a quick ratio of 2.87. The company's fifty day moving average price is $38.33 and its 200 day moving average price is $45.87. The company has a market capitalization of $2.01 billion, a PE ratio of 88.10 and a beta of 0.90. LivaNova PLC has a one year low of $32.48 and a one year high of $64.48.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.

Want to see what other hedge funds are holding LIVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LivaNova PLC (NASDAQ:LIVN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.